Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity?

被引:31
|
作者
Reich, Arno
Spering, Christopher
Schulz, Joerg B. [1 ]
机构
[1] Univ Gottingen, Dept Neurodegenerat & Restorat Res, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany
关键词
D O I
10.1016/j.tins.2008.06.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
For over a decade, neuroscientific research has focused on processes of apoptosis and its contribution to the pathophysiology of neurological diseases. In the central nervous system, the degree of intrinsic mitochondrial-mediated apoptotic signaling expresses a cell's individual metabolic stress, whereas activation of the extrinsic death receptor-induced cascade is regarded as a sign of imbalanced cellular networks. Under physiological conditions, most neurons possess death receptors without being sensitive to receptor-mediated apoptosis. This paradox raises two questions: what is the evolutionary advantage of expressing potentially harmful proteins? How is their signaling controlled? This review summarizes the functional relevance of FasL-Fas signaling - a quintessential death ligand/receptor system - in different neurological disease models ranging from traumatic, inflammatory and ischemic to neurodegenerative processes. Furthermore, it outlines alternative non-apoptotic Fas signaling, shedding new light on its neuroplastic capacity. Finally, receptor-proximal regulatory proteins are introduced and identified as potential protagonists of disease-modifying neurological therapies.
引用
收藏
页码:478 / 486
页数:9
相关论文
共 50 条
  • [21] Helicobacter pylori induced apoptosis is mediated by the CD95 (fas) receptor and ligand system
    Rudi, J
    Kuck, D
    von Herbay, A
    Krammer, PH
    Galle, PR
    Stremmel, W
    GUT, 1998, 43 : A14 - A14
  • [22] Regulation of death receptor-induced apoptosis induced via CD95/Fas and other death receptors
    I. N. Lavrik
    Molecular Biology, 2011, 45 : 150 - 155
  • [23] Death Induced by CD95 or CD95 Ligand Elimination
    Hadji, Abbas
    Ceppi, Paolo
    Murmann, Andrea E.
    Brockway, Sonia
    Pattanayak, Abhinandan
    Bhinder, Bhavneet
    Hau, Annika
    De Chant, Shirley
    Parimi, Vamsi
    Kolesza, Piotre
    Richards, JoAnne
    Chandel, Navdeep
    Djaballah, Hakim
    Peter, Marcus E.
    CELL REPORTS, 2014, 7 (01): : 208 - 222
  • [24] Death the Fas way: regulation and pathophysiology of CD95 and its ligand
    Sharma, K
    Wang, RX
    Zhang, LY
    Yin, DL
    Luo, XY
    Solomon, JC
    Jiang, RF
    Markos, K
    Davidson, W
    Scott, DW
    Shi, YF
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) : 333 - 347
  • [25] CD95/Fas protects cancer cells from cell death
    Hadji, Abbas
    Hau, Annika
    Peter, Marcus E.
    CANCER RESEARCH, 2012, 72
  • [26] Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome
    Baiocchi, RA
    Khatri, VP
    Lindemann, MJ
    Ross, ME
    Papoff, G
    Caprio, AJ
    Caprio, TV
    Fenstermaker, R
    Ruberti, G
    Bernstein, ZP
    Caligiuri, MA
    BLOOD, 1997, 90 (05) : 1737 - 1746
  • [27] CD95 (APO-1/Fas)-induced hepatocyte death
    Galle, PR
    Strand, S
    Muller, M
    Hug, H
    Otto, G
    Hofmann, WJ
    Krammer, PH
    Stremmel, W
    AUTOIMMUNE LIVER DISEASE, 1997, : 8 - 12
  • [28] Localization and expression of Fas (CD95) ligand (FasL) and Fas receptor (Fas) in the rat epididymis
    Griffin, FC
    Lowe, DA
    Lund, T
    Cameron, DF
    FASEB JOURNAL, 1997, 11 (03): : 3569 - 3569
  • [29] Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex
    Vassilev, A
    Ozer, Z
    Navara, C
    Mahajan, S
    Uckun, FM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) : 1646 - 1656
  • [30] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687